Company experts elevate best practices in patient access, AI innovation, gross-to-net management, and copay strategy

ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, recently showcased its commanding expertise across the patient services ecosystem with thought leadership roles at two major industry events – the Copay, Reimbursement and Access Congress and the Patient Support Services Congress.

ConnectiveRx experts shaped the conversation regarding AI’s practical applications in patient support, accumulators and maximizers, gross-to-net management strategies, and evolving manufacturer market access programs amid regulatory uncertainty.

Chris Dowd Delivers Copay Industry Outlook, Leads Policy Impact Panel

Chris Dowd, SVP of Market Development, served as returning chairperson of the 2025 Copay, Reimbursement and Access Congress. His opening “Industry Outlook” covered the rise of maximizers, policy shifts shaping 2026, and the growing expectation that innovation must be backed by strong execution. At the Patient Support Services Congress, Dowd moderated a forward-looking session on how shifting federal priorities are reshaping the patient services landscape and demanding more agile, future-proofed support programs. Dowd continues to advance these themes in his ongoing Pharmaceutical Commerce expert series.

Ticia Cawley, Simon Kasmir, and Kristine McGaughey Guide Peer Dialogue

At the Patient Support Services Congress, Ticia Cawley, VP Client Solutions, and Kristine McGaughey, VP Implementation, served as Track Chairs, developing insights on integrated patient support models. McGaughey, recently named to PM360’s ELITE 100 and a speaker on hub readiness earlier this year, joined ConnectiveRx's Simon Kasmir to facilitate a Gross-to-Net session guiding manufacturers through strategies to counter PBM practices as well as alternative funding risk and suspicious pharmacy activity.

Steve Randall Delivers High-Impact AI Session at Patient Support Services Kickoff

ConnectiveRx Chief Technology Architect Steve Randall, who was also recently named to PM360’s ELITE 100, delivered a standing-room session on evaluating AI for patient outcomes in hub services—outlining where automation is already improving speed, consistency, and enrollment accuracy, and what “good” AI deployment looks like in terms of measurable results.

This exploration of how automation strengthens (versus weakening) patient-brand relationships built on Randall’s recent Pharmaceutical Commerce Q&A, which explores the AI questions access teams aren’t asking – but should be.

About ConnectiveRx

ConnectiveRx is a leading technology-enabled pharmaceutical services company that provides patient and provider support, access and adherence solutions for specialty and branded medications. The company’s services include the industry’s leading patient engagement and access platform (hub services), patient and provider adherence messaging, patient affordability programs, and the iconic Physicians’ Desk Reference, now known as the Prescribers’ Digital Reference. ConnectiveRx’s wide array of services and innovative solutions accelerate speed-to-therapy and increase access and adherence, resulting in improved outcomes for patients and healthcare overall. To learn more, visit www.connectiverx.com or follow us on LinkedIn @ConnectiveRx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251215316684/en/

ConnectiveRx experts shaped the conversation regarding AI’s practical applications in patient support, accumulators and maximizers, gross-to-net management strategies, and evolving manufacturer market access programs amid regulatory uncertainty.